Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Central Nervous System Drugs 60
Endocrine and Metabolic Disorders Drugs 46
Drug Discovery 32
Infusions and Injectables 25
Musculoskeletal Disorders Drugs 24
Surgical Procedures 20
Pharmaceuticals 17
Biopharmaceuticals 15
Prostate Cancer Drugs 12
Clinical Trials 12
Drug Delivery 11
Liver Cancer Drugs 10
Women's Health 10
Neurology 9
Dermatology 9
Pancreatic Cancer Drugs 9
Lung Cancer Drugs 8
Biotechnology 7
Healthcare Services 7
Immune Disorders Drugs 7
Medical Devices 7
Breast Cancer Drugs 6
Diagnostics 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Thyroid Cancer Drugs 6
Company Reports 5
Ovarian Cancer Drugs 5
Oncology 5
Dermatological Drugs 5
Sexual and Reproductive Health Drugs 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Genomics 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Healthcare 2
Diabetes Devices 2
Needles and Syringes 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Skin Cancer Drugs 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Manufacturing 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Transdermal and Transmucosal Drug Delivery 1
Biomaterials 1
Hematology 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

419 Results (Page 7 of 21)
- Relevance
  Sort by

Sarcoma Drugs Market by Indication, Drugs, Sales Channel, End-User - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Antineoplastic Agents Market by Type, Structure, Indication, Application, End-User - Global Forecast 2025-2030

 Report
October 2024
198 Pages
Global

From

€3501EUR$3,545USD£2,923GBP

€3890EUR$3,939USD£3,248GBP

Botox Market 2024-2028

 Report
January 2024
154 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

 Report
May 2024
50 Pages
United States

€10164EUR$10,653USD£8,200GBP

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

 Report
November 2023
250 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

 Report
June 2024
64 Pages
Global

€10164EUR$10,653USD£8,200GBP

Acromegaly Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
August 2022
168 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
1079 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Facial Aesthetics Devices - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5530EUR$5,600USD£4,618GBP

Gastrointestinal Stromal Tumors Therapeutics Market 2024-2028

 Report
December 2023
165 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

USA Solid Tumor Therapeutics Market Outlook to 2028

 Report
October 2023
85 Pages
United States

From

€4789EUR$4,850USD£3,999GBP

Rare Diseases Market Report 2024-2034

 Report
May 2024
344 Pages
Global

From

€5392EUR$5,651USD£4,350GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Fibrodysplasia ossificans progressiva - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1037EUR$1,050USD£866GBP

€1481EUR$1,500USD£1,237GBP

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
1834 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
70 Pages
Global

From

€3456EUR$3,500USD£2,886GBP

Ethical Pharmaceuticals Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Controlled Substance Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Botulinum Toxin Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

 Report
May 2024
381 Pages
Global

From

€3587EUR$3,633USD£2,996GBP

€5125EUR$5,190USD£4,279GBP

419 Results (Page 7 of 21)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.